文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

嵌合抗原受体 T 细胞能引发抗肿瘤免疫。

CAR T cells ignite antitumor immunity.

机构信息

Department of Hematology and Hematopoietic Cell Transplantation (T Cell Therapeutics Research Laboratories), City of Hope, Beckman Research Institute and Medical Center, Duarte, CA 91010, USA.

Department of Hematology and Hematopoietic Cell Transplantation (T Cell Therapeutics Research Laboratories), City of Hope, Beckman Research Institute and Medical Center, Duarte, CA 91010, USA.

出版信息

Trends Immunol. 2023 Oct;44(10):748-750. doi: 10.1016/j.it.2023.08.002. Epub 2023 Aug 29.


DOI:10.1016/j.it.2023.08.002
PMID:37652814
Abstract

Broadening immune responses through antigen spreading remains the 'Holy Grail' of cancer immunotherapy. A study by Ma and colleagues reveals that vaccine boosting of chimeric antigen receptor (CAR)-T cells in mice promotes endogenous immunity and elicits antigen spread to eliminate antigenically heterogenous solid tumors through a mechanism crucially dependent on interferon (IFN)γ.

摘要

通过抗原扩散来拓宽免疫反应仍然是癌症免疫治疗的“圣杯”。马及其同事的一项研究表明,在小鼠中增强嵌合抗原受体 (CAR)-T 细胞的疫苗会促进内源性免疫,并通过一种关键依赖于干扰素 (IFN)γ的机制引发抗原扩散,从而消除抗原异质性的实体瘤。

相似文献

[1]
CAR T cells ignite antitumor immunity.

Trends Immunol. 2023-10

[2]
Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity.

Cell. 2023-7-20

[3]
IFNγ Is Critical for CAR T Cell-Mediated Myeloid Activation and Induction of Endogenous Immunity.

Cancer Discov. 2021-9

[4]
Bispecific CAR T Cells against EpCAM and Inducible ICAM-1 Overcome Antigen Heterogeneity and Generate Superior Antitumor Responses.

Cancer Immunol Res. 2021-10

[5]
Enhanced CAR-T cell activity against solid tumors by vaccine boosting through the chimeric receptor.

Science. 2019-7-12

[6]
Enhanced Cancer Immunotherapy by Chimeric Antigen Receptor-Modified T Cells Engineered to Secrete Checkpoint Inhibitors.

Clin Cancer Res. 2017-9-14

[7]
Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting.

Clin Cancer Res. 2017-5-15

[8]
Preclinical Evaluation of Chimeric Antigen Receptor-Modified T Cells Specific to Epithelial Cell Adhesion Molecule for Treating Colorectal Cancer.

Hum Gene Ther. 2019-3-13

[9]
Regional CAR T cell therapy: An ignition key for systemic immunity in solid tumors.

Cancer Cell. 2022-6-13

[10]
Tumor Antigen and Receptor Densities Regulate Efficacy of a Chimeric Antigen Receptor Targeting Anaplastic Lymphoma Kinase.

Mol Ther. 2017-7-1

引用本文的文献

[1]
Strategies to overcome tumour relapse caused by antigen escape after CAR T therapy.

Mol Cancer. 2025-4-28

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索